QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, January 5, 2005, 25(1):157-163; doi:10.1523/JNEUROSCI.3842-04.2005

This Article Full Text Full Text (PDF) A correction has been published Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (24) Citing Articles via Google Scholar Google Scholar Articles by Morton, A. J. Articles by Maywood, E. S. Search for Related Content PubMed PubMed Citation Articles by Morton, A. J. Articles by Maywood, E. S.

 Previous Article  |  Next Article 

Cellular/Molecular
Disintegration of the Sleep-Wake Cycle and Circadian Timing in Huntington's Disease

A. Jennifer Morton,¹ Nigel I. Wood,¹ Michael H. Hastings,² Carrie Hurelbrink,³ Roger A. Barker,³ and Elizabeth S. Maywood²

¹Department of Pharmacology, University of Cambridge, Cambridge CB2 1PD, United Kingdom, ²Medical Research Council Laboratory of Molecular Biology, Cambridge CB2 2QH, United Kingdom, and ³Brain Repair Centre, Department of Clinical Neurosciences, Addenbrooke's Hospital, Cambridge CB2 2PY, United Kingdom

Sleep disturbances in neurological disorders have a devastating impact on patient and carer alike. However, their pathological origin is unknown. Here we show that patients with Huntington's disease (HD) have disrupted night-day activity patterns. This disruption was mirrored in a transgenic model of HD (R6/2 mice) in which daytime activity increased and nocturnal activity fell, eventually leading to the complete disintegration of circadian behavior. The behavioral disturbance was accompanied by marked disruption of expression of the circadian clock genes mPer2 and mBmal1 in the suprachiasmatic nuclei (SCN), the principal circadian pacemaker in the brain. The circadian peak of expression of mPer2 was prematurely truncated, and the mRNA levels of mBmal1 were attenuated and failed to exhibit a significant circadian oscillation. Circadian cycles of gene expression in the motor cortex and striatum, markers of behavioral activation in wild-type mice, were also suppressed in the R6/2 mice, providing a neural correlate of the disturbed activity cycles. Increased daytime activity was also associated with reduced SCN expression of prokineticin 2, a transcriptional target of mBmal1 encoding a neuropeptide that normally suppresses daytime activity in nocturnal mammals. Together, these molecular abnormalities could explain the pathophysiological changes in circadian behavior. We propose that circadian sleep disturbances are an important pathological feature of HD, that they arise from pathology within the SCN molecular oscillation, and that their treatment will bring appreciable benefits to HD patients.

Key words: clock; per 2; suprachiasmatic nucleus; neurodegeneration; polyglutamine repeat; hypothalamus; R6/2 mouse; prokineticin

---

Received Sep 16, 2004; revised November 5, 2004; accepted November 5, 2004.

This article has been cited by other articles:

				M. Politis, N. Pavese, Y. F. Tai, S. J. Tabrizi, R. A. Barker, and P. Piccini Hypothalamic involvement in Huntington's disease: an in vivo PET study Brain, November 1, 2008; 131(11): 2860 - 2869. [Abstract] [Full Text] [PDF]

				A. G. Walker, B. R. Miller, J. N. Fritsch, S. J. Barton, and G. V. Rebec Altered Information Processing in the Prefrontal Cortex of Huntington's Disease Mouse Models J. Neurosci., September 3, 2008; 28(36): 8973 - 8982. [Abstract] [Full Text] [PDF]

				I. Arnulf, J. Nielsen, E. Lohmann, J. Schieffer, E. Wild, P. Jennum, E. Konofal, M. Walker, D. Oudiette, S. Tabrizi, et al. Rapid Eye Movement Sleep Disturbances in Huntington Disease Arch Neurol, April 1, 2008; 65(4): 482 - 488. [Abstract] [Full Text] [PDF]

				P. N. Pallier, E. S. Maywood, Z. Zheng, J. E. Chesham, A. N. Inyushkin, R. Dyball, M. H. Hastings, and A. Jennifer Morton Pharmacological Imposition of Sleep Slows Cognitive Decline and Reverses Dysregulation of Circadian Gene Expression in a Transgenic Mouse Model of Huntington's Disease J. Neurosci., July 18, 2007; 27(29): 7869 - 7878. [Abstract] [Full Text] [PDF]

				A. D. Steele, W. S. Jackson, O. D. King, and S. Lindquist The power of automated high-resolution behavior analysis revealed by its application to mouse models of Huntington's and prion diseases PNAS, February 6, 2007; 104(6): 1983 - 1988. [Abstract] [Full Text] [PDF]

				H. M. Prosser, A. Bradley, J. E. Chesham, F. J. P. Ebling, M. H. Hastings, and E. S. Maywood Prokineticin receptor 2 (Prokr2) is essential for the regulation of circadian behavior by the suprachiasmatic nuclei PNAS, January 9, 2007; 104(2): 648 - 653. [Abstract] [Full Text] [PDF]

				Q.-Y. Zhou The Prokineticins: A NOVEL PAIR OF REGULATORY PEPTIDES Mol. Interv., December 1, 2006; 6(6): 330 - 338. [Abstract] [Full Text] [PDF]

				S.-i. Matsumoto, C. Yamazaki, K.-h. Masumoto, M. Nagano, M. Naito, T. Soga, H. Hiyama, M. Matsumoto, J. Takasaki, M. Kamohara, et al. Abnormal development of the olfactory bulb and reproductive system in mice lacking prokineticin receptor PKR2. PNAS, March 14, 2006; 103(11): 4140 - 4145. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help